Early Elevation of Lipoprotein(a) Levels in Chronic Renal Insufficiency

References

• Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904–910
   PubMed Web of Science ®Google Scholar
• Mbewu A D, Durrington P N. Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990; 85: 1–14
   PubMed Web of Science ®Google Scholar
• Dahlen G H, Guyton J R, Atlar M, Farmer J A, Kantz J A, Gotto A M. Association of levels of lipoprotein Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–765
   PubMed Web of Science ®Google Scholar
• Rhoads G G, Dahlen G H, Berg K, Morton N E, Dannenberg A L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986; 256: 2540–2544
   PubMed Web of Science ®Google Scholar
• Murai A T, Miyahara N, Fujimoto M, Matusda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 62: 249–257
   PubMedGoogle Scholar
• Valentine R J, Grayburn P A, Vega D L, Grundy S M. Lp(a) lipoprotein is an independent discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med 1994; 154: 801–806
   PubMed Web of Science ®Google Scholar
• Gault M H, Longerich L L, Harnett J, Breckenridge C. Comparison of Lp(a) concentrations and some potential effects in hemodialysis, transplantation, and controls groups, and review of the literature. Nephron 1995; 70: 155–170
   PubMedGoogle Scholar
• Kronenberg F, Köning P, Neyer U, Auinger M, Pribasnig A, Lang U, Reitinger J, Pinter G, Utermann G, Dieplinger H. Multicenter study of Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with endstage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6: 110–120
   PubMed Web of Science ®Google Scholar
• Heimann P, Josephson M A, Fellner S K, Thistlethwaite, Jr, Stuart F P, Dasgupta A. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients. Am J Nephrol 1991; 11: 470–474
   PubMedGoogle Scholar
• Webb A T, Reaveley D A, O'Donnell M, O'Connor B, Seed M, Brown E A. Does cyclosporin increase lipoprotein(a) concentrations in renal transplant patients?. Lancet 1993; 341: 268–270
   PubMedGoogle Scholar
• Cressman M D, Heyka R J, Paganine E P, O'Neil J, Sikibinski C I, Hoff H F. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86: 475–482
   PubMed Web of Science ®Google Scholar
• Del Cura J, Gil-Paraiso A, Borque L, Carazo M E, Maside C, Sanchez-Casajús A. Lipoprotein(a) in chronic renal failure patients undergoing hemodialysis: does it have an independent role in the development of further cardiovascular complications? (letter). Nephron 1993; 65: 644–645
   PubMedGoogle Scholar
• Docci D, Manzoni G, Baldrati L, Campocini C, Neri L, Feletti C. Serum lipoprotein(a) as an independent cardiovascular risk factor for patients undergoing chronic hemodialysis (letter). Nephron 1995; 69: 195
   PubMedGoogle Scholar
• Kandousi A, Cachera C, Pagniez D, Dracon M, Fruchart J C, Tacquet A. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis but not in CAPD. Kidney Int 1992; 42: 424–425
   PubMedGoogle Scholar
• Irish A B, Simons L A, Savdie E, Hayes J M, Simons J. Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation. Aust NZ J Med 1992; 22: 243–248
   PubMedGoogle Scholar
• Kronenberg F. Lipoprotein(a) in renal disease: what we have, what we need, what we can forget (editorial comment). Nephrol Dial Transplant 1995; 10: 766–769
   PubMedGoogle Scholar
• Black I W, Wilken D EL. Decrease of apolipoprotein(a) after renal transplantation: implications for lipoprotein(a) metabolism. Clin Chem 1992; 38: 353–357
   PubMed Web of Science ®Google Scholar
• Kronenberg F, Köning P, Lhotta K, Königsrainer A, Sandholzer C, Utterman G, Dieplinger H. Cyclosporin and serum lipids in renal transplant recipients (letter). Lancet 1993; 341: 765
   PubMedGoogle Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low density lipoprotein cholesterol without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Haffner S M, Gruber K K, Aldrete G, Jr., Morales P A, Stern M P, Tuttle K R. Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol 1992; 3: 1156–1162
   PubMedGoogle Scholar
• Okura Y, Saku K, Hirata K, Zhang B, Liu R, Ogahara S, Naito S, Kajiyama G, Arakawa K. Serum lipoprotein(a) levels in maintenance hemodialysis patients. Nephron 1993; 65: 46–50
   PubMed Web of Science ®Google Scholar
• Barbagallo C M, Averna M R, Sparacino V, Galione A, Caputo F, Scafidi V, Amato S, Mancino C, Cefalù A B, Notarbartolo A. Lipoprotein(a) levels in end-stage renal failure and renal transplantation. Nephron 1993; 64: 560–564
   PubMedGoogle Scholar
• Takegoshi T, Kitoh C, Yamazaki Y. A study of the clinical significance of Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Nip J Gokka Shi 1990; 32: 667–671
   PubMedGoogle Scholar
• Buggy D, Breathnach A, Keogh B, Cooke T, Feely J. Lipoprotein(a) and treatment of chronic renal disease. J Intern Med 1993; 234: 453–455
   PubMedGoogle Scholar
• Kronenberg F, König P, Lhotta K, Öfner D, Sandhölzer C, Margreiter R, Dosch E, Utermann G, Dieplinger H. Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arterioscler Thromb 1994; 14: 1399–1404
   PubMedGoogle Scholar
• Steinmüller T M, Klaus-Jürgen G, Schleicher J, Leder K, Bechstein W O, Mueller A R, Dette K, Schulz E, Neuhaus P. The effect of FK506 versus cyclosporin on glucose and lipid metabolism—a randomized trial. Transplantation 1994; 58: 669–674
   PubMedGoogle Scholar
• Grundy S M. Management of hyperlipidemia of kidney disease (editorial). Kidney Int 1990; 37: 847–853
   PubMed Web of Science ®Google Scholar
• De Lima J JG, Diament J, Gianini S D, Horta P E, Giorgi M CP, Krieger E M, Pileggi F. Plasma lipid profile and coronary artery disease in Brazilian hemodialysis population. Int J Cardiol 1995; 48: 163–166
   PubMedGoogle Scholar
• Borba E F, Santos R D, Bonfa E, Vinagre C G, Pileggi F JC, Cossermelli W, Maranhao R C. Lipoprotein(a) levels in systemic lupus erythematosus. J Rheumatol 1994; 21: 220–223
   PubMed Web of Science ®Google Scholar
• Karadl I, Romics L, Palos G, Doman J, Kaszas I, Hesz A, Kostner G M. Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 1989; 35: 2121–2123
   PubMedGoogle Scholar